As shown in Fig. 1a, b, the number of dermal DCs exhibiting ALDH activity was decreased in BLM-treated Fli1+/− mice compared with BLM-treated WT mice, and the majority of dermal DCs with ALDH activity were CD103−CD11b− DCs in both strains. Here, FLI1 is linked to Bloom syndrome.